Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Linagliptin's Effect on CD34+ Stem Cells

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02467478
Recruitment Status : Active, not recruiting
First Posted : June 10, 2015
Last Update Posted : July 30, 2019
Sponsor:
Collaborator:
Boehringer Ingelheim
Information provided by (Responsible Party):
Sabyasachi Sen, George Washington University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : April 2019
Estimated Study Completion Date : December 2019